In a report released today, Alec Stranahan from Bank of America Securities maintained a Buy rating on Revolution Medicines (RVMD – ...

Revolution Medicines has a 1 year low of $20.51 and a 1 year high of $62.40. The company’s fifty day moving average is $49.68 and its two-hundred day moving average is $44.24.

US Bancorp DE lessened its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 16.8% in the 3rd quarter, Holdings Channel reports. The firm owned 2,455 shares of the company ...

To access the live webcasts, please visit the “Events & Presentations” page of Revolution Medicines’ website at https://ir.revmed.com/events-and-presentations ...

SEC Filings provided by EDGAR Online, Inc.

Revolution Medicines Inc's commitment to precision oncology positions it at the forefront of targeted cancer therapies. Despite a strong research pipeline, the company faces the challenges of a ...

If you’re on the fence about investing in Alkermes plc, Revolution Medicines or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...

This page features the latest news about the Revolution Med stock. Revolution shares target raised to $73 by Jefferies on new data On Monday, Jefferies updated its outlook on Revolution (NASDAQ ...